Valvular Heart Disease and Pulmonary Arterial Hypertension
- FINTEPLA can cause valvular heart disease and pulmonary arterial hypertension. (5.1)
- Echocardiogram assessments are required before, during, and after treatment with FINTEPLA. (2.1, 2.6, 5.1)
- FINTEPLA is available only through a restricted program called the FINTEPLA REMS. (5.2)
Patient counseling
REMS
Medical guidelines
Package inserts
Keywords: Fintepla
Updated: November 2025
